Skip to main content
. 2019 Oct 19;5:25. doi: 10.1186/s41016-019-0172-9

Fig. 5.

Fig. 5

In vivo targeting of glioblastoma tumors by He μCAP [34]. a A new μCAP device used in plasma delivery by means of an intracranial endoscopic tube to direct at glioblastoma tumors in the brain of the mouse. b Representative bioluminescence images in vivo demonstrating the volume of glioblastoma tumor (such as radiance or light emission) at baseline and 2 days after the treatment of He μCAP or vehicle (helium). Areas of low photon emission are indicated in blue and high are indicated in red